Evidence map›Paper›PMID 39110896›Full record

ArticleJournal of neurophysiology2024

Sustained fentanyl exposure inhibits neuronal activity in dissociated striatal neuronal-glial cocultures through actions independent of opioid receptors.

Viktor Yarotskyy, Sara R Nass, Yun-Kyung Hahn, Liangru Contois, A Rory McQuiston, Pamela E Knapp, Kurt F Hauser

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Frozen in Addiction: A New Wave of Drug-Induced Movement Disorders?Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Viktor YarotskyyDepartment of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.ORCID 0000-0002-9247-6975
Sara R NassDepartment of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.ORCID 0000-0003-1868-1257
Yun-Kyung HahnDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
Liangru ContoisDepartment of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.ORCID 0000-0002-5719-8439
A Rory McQuistonDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
Pamela E KnappDepartment of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
Kurt F HauserDepartment of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.ORCID 0000-0001-7886-0332

Funding

Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidityR01DA057346 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kurt F Hauser, Pamela E Knapp · 2022 to 2026
$3.4M
Selective vulnerability of discrete neural circuits in the striatum to HIV-opiate comorbidityR01DA045588 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F · 2018 to 2022
$2.0M
Opioid and non-opioid receptor mechanisms in neurons and glia underlying fentanyl and HIV comorbidity in the striatumR01DA060724 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kurt F Hauser, Viktor Yarotskyy · 2024 to 2026
$2.0M
Chloride channel-dependent mechanisms of opiate and HIV-induced synaptodendritic injuryR21DA057153 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F, YAROTSKYY, VIKTOR · 2022 to 2023
$427k
HIV and opiate interactions in behavioral and anterior cingulate cortex synaptic dysfunctionF32DA053163 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI NASS, SARA · 2021 to 2022
$140k
HHS | NIH | National Institute on Drug Abuse (NIDA) DA045588HHS | NIH | National Institute on Drug Abuse (NIDA) DA053163HHS | NIH | National Institute on Drug Abuse (NIDA) DA057153HHS | NIH | National Institute on Drug Abuse (NIDA) DA057346HHS | NIH | National Institute on Drug Abuse (NIDA) DA060724NIDA NIH HHS F32 DA053163NIDA NIH HHS R01 DA045588NIDA NIH HHS R01 DA057346NIDA NIH HHS R01 DA060724NIDA NIH HHS R21 DA057153
6 · The paper itself

Abstract

Besides having high potency and efficacy at the µ-opioid (MOR) and other opioid receptor types, fentanyl has some affinity for some adrenergic receptor types, which may underlie its unique pathophysiological differences from typical opioids. To better understand the unique actions of fentanyl, we assessed the extent to which fentanyl alters striatal medium spiny neuron (MSN) activity via opioid receptors or α

Indexed as

Action PotentialsAnalgesics, OpioidCoculture TechniquesCorpus StriatumFentanylNeurogliaNeuronsAnimalsCells, CulturedMaleMiceNarcotic AntagonistsReceptors, Dopamine D1Receptors, Dopamine D2Receptors, OpioidAnalgesics, OpioidFentanylNarcotic AntagonistsReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Opioidadrenergic receptorfentanylmedium spiny neuronopioidopioid receptor

Identifiers

PMID39110896
PMCPMC11427067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.